Preliminary results from FLAGSHP-1: A phase 1 study of ERAS-601 as a monotherapy or in combination with cetuximab in patients (pts) previously treated for advanced chordoma Meeting Abstract
| Authors: | Gounder, M. M.; Rosen, E.; Parikh, A. R.; Conley, A. P.; Hong, D. S.; Sheth, S.; Mai, N.; Sgroe, E.; Mitchell, R.; Picard, R.; Brail, L. H.; Cote, G. M. |
| Abstract Title: | Preliminary results from FLAGSHP-1: A phase 1 study of ERAS-601 as a monotherapy or in combination with cetuximab in patients (pts) previously treated for advanced chordoma |
| Meeting Title: | 2024 ASCO Annual Meeting |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 42 |
| Issue: | 16 Suppl. |
| Meeting Dates: | 2024 May 31-Jun 4 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2024-06-01 |
| Language: | English |
| ACCESSION: | WOS:001275557402680 |
| PROVIDER: | wos |
| DOI: | 10.1200/JCO.2024.42.16_suppl.11522 |
| Notes: | Meeting Abstract: 11522 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
Related MSK Work